NextSource Biotechnology Gains FDA Approval For New 5 Mg Strength Of Gleostine (Lomustine), An Anti-Cancer Chemotherapy Agent .. MIAMI, Jan. 20, 2016 /PRNewswire/ -- NextSource Biotechnology, LLC announced today that Gleostine (lomustine) 5 mg capsules has been approved by the U.S. Food and Drug Administration (FDA) and is now commercially available in the United States. February 16, 2022; Goodwin Biotechnology CEO Karl Pinto on Delivering Integrated Manufacturing Solutions for Complex Biopharmaceuticals . Home / Who We Are / Goodwin Biotechnology in the News / Press Releases. June 4, 2022 Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma . Date. Start with a message and a plan. Press Releases. Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results. 02.28.22 || Catamaran Bio Announces Appointment of Michael DeRidder, PhD, as Senior Vice President, Corporate Strategy and New Product Planning. * Required. 4/27/22. Press Releases Year. CAMBRIDGE, Mass. Press release from Excelra Knowledge Solutions Pvt. SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today a new ELISA test that measures. June 23, 2020 Read more . 3. Title. Press Releases. News Releases . University of Wisconsin Applied Biotechnology Faculty, Mark Levenstein, Wins Regent Scholar Award for Research on Agrochemicals . COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) - Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, announced today that it has entered into a committed equity purchase agreement (the "Agreement") with Lincoln Park Capital Fund, LLC ("LPC"), for the issuance . Date . HO WAH GENTING BERHAD'S JV PARTNER, EBI APPROACHED BY AMERICAN FUSE GROUP HOLDING INC. (OTCQB: FUST) TO ACQUIRE 100% EQUITY INTEREST OF ITS HOLDING COMPANY, WITH INTENTION TO LIST ON NASDAQ STOCK MARKET. Solvay is launching a new Renewable Materials and Biotechnology platform, dedicated to developing innovative and sustainable solutions for a range of markets, using renewable feedstocks and biotechnology. The first paragraph of your press release, much like a journalist's 'lead' will in most cases summarize the most important parts of the PR in one . Biotech Showcase 2018 Presentation. 5/5/22. Contact. Signing of Memorandum of Understanding (MoU) between Ministry of Ayush and Department of Biotechnology, Government of India. Below are our most recent news releases. Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass. News Releases Year: Items per . It has been an The company is already a market leader in some bio-based products, including guar, bio-sourced solvents and natural vanillin, the latter of . 2022; 2021; 2020; 2019; 2018; 2017; News Title Date; Duopharma Biotech Q1 2022 Financial Result: 17/05/2022: Duopharma Biotech Pledges Carbon Neutrality and Net Zero Goals: . Press Release. IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial. Lead / First paragraph . Press Releases. Awakn Life Sciences Corp., a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder, announced today . ET . SAN DIEGO , June 02, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the 2022 Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m. release 9 March 2022 Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG Read press release 23 February 2022 BRAIN Biotech AG: Very Dynamic Start . Press Release. The Global Biotech Partnering Terms and NEW YORK, Dec. 7, 2021 /PRNewswire/ -- Linus Biotechnology Inc., a leader in precision exposome sequencing, today announced that the U.S. Food and Drug Administration Center for Devices and . March 18, 2022 . Facebook. SEC Filings. 2021-02-05 09:59:14. SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced 12-week data from its ongoing Phase 1 safety study of UBX1325 in patients with advanced disease from diabetic macular . 2021. Investors Home. May 19, 2022 - MAIA Biotechnology, Inc. Press Releases Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. Oncology Tube Profiles Acceleration of Dosing in AVM NHL Clinical Trial. VERSATILE-002 - Preliminary Phase 2 Results in Recurrent or Metastatic Head and Neck Cancer: 76.5% of patients had either disease stabilization or tumor shrinkage; 89% of patients alive at median 9 months suggesting survival benefit. 2019; 2018; 2017; 2016; 2015; 2014; 2013; 2012; 2011; 2010; 2008; 2007; 2006; 2005; 2004; 2003; 2002; . May 27, 2022 Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement responding to recent incidences of gun violence across the country: "I couldn't sleep last night. Biotechnology Press Releases Smileyscope Welcomes Critically Acclaimed and Clinically Validated Forest of Serenity Onto Its VR Therapeutic Platform NEW YORK, NY, Feb 22, 2022 New York- and Australia- based, Smileyscope Holding Inc (Smileyscope). Review the latest news on our company, products, and research. The Global Biotech Partnering Terms and This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. ADVERTISE. 3. The U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory . LAS VEGAS, May 23, 2022--PharmaCyte Biotech, Inc. (NASDAQ . Linkedin. . 4. SQZ Biotech Launches SQZ Cell Therapy Platform and Is Awarded $100,000 Grand Prize from MassChallenge and over $200,000 from Boeing and the Center for the Advancement of Science in Space (CASIS) . 2020. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities. . Quote If you've chosen to adapt a standard press release format, at this point the quotes from company leaders about the announcement should come in. Press release year list 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011. . 202.962.9235. [email protected]. 01/04/2022. September 6, 2021 SQZ Biotechnologies seeks to expand the universe of cell therapies . Progress for patients. Union Minister Dr. Jitendra Singh launches a major futuristic PPP mode initiative for 'Clean Energy' with the full launch of "Mission Integrated Bio-refineries" to accelerate Clean Energy solutions . Announces FDA Orphan Drug Designation for THIO for the Treatment of Hepatocellular Carcinoma (HCC) The Global Biotech Partnering Terms and Agreements 2017 to 2022 report provides comprehensive access to available deals and contract documents for over 6,500 Biotech deals. LEARN MORE. Puma Biotechnology Releases Updated Corporate Presentation. The Biotechnology Innovation Organization (BIO) announced today the retirement of Senior Vice President and Chief Financial Officer (CFO), Yvette White-Wiggins, after a distinguished 18-year career with the organization. DURHAM, N.C., March 1, 2021 Ed Pagani, PhD, a. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements about Sana Biotechnology, Inc. (the "Company," "we," "us," or "our") within the meaning of the federal securities laws, including those related to the Company's vision; and the Company's participation in the Goldman Sachs 43rd Annual Global Healthcare Conference; and . by Kyle | May 3, 2021 | Press Release. Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that NASDAQ has halted trading of the company's common stock. Read More. DUBLIN, June 8, 2022 /PRNewswire/ -- The "Global Biotech Partnering Terms and Agreements 2017-2022" report has been added to ResearchAndMarkets.com's offering. Press Releases Select Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test Words such as "may," "will," "plan," "potential," "aim," "promising" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are . Pharma, biotech, FDA, gene therapy, clinical trials, drug pricing and much more. May 12, 2022. White-Wiggins rose through the ranks at BIO and served as CFO since 2016, building a solid . . PDS0101 - 2022 ASCO NEWS. A71D6692-5CFE-4689-B857-C80775B0E4E8. For an example, a biotech company may want to be perceived as an excellent drug discovery collaborator so that . Press Releases Press Releases Year. Our guidelines for sending a biotech press release are listed in chronological order. May 5, 2021 | Press Releases. Biogen, Bio-Thera Presents Positive Phase 3 Data For Tocilizumab Biosimilar In Rheumatoid Arthritis At the Annual European Congress of Rheumatology on Friday, biotechnology companies Biogen Inc. (BIIB) and Bio-Thera Solutions, Ltd. presented positive Phase 3 data for . November 9, 2021. MIRAMAR, Fla., May 05, 2021 (GLOBE NEWSWIRE) Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) ("Generex" or the "Company"), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the. . Press Releases Press Releases Year. None 2022 2021 2020 2019 2018 2017. Luzsana Biotechnology (Luzsana) is a global, purpose-driven innovative medicines company with the mission to deliver medicines that are available, accessible and affordable to anyone, anywhere. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act. Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer . Get the latest news Biotech industry news and articles online. . 2022. Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights. . Puma Biotechnology's NERLYNX Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer. Kane Biotech Obtains ISO 13485 . Older Entries. Statement from BIOTECanada on Health Canada Approval of the Pfizer-BioNTech COVID-19 Vaccine (December 9, 2020); PMPRB Guidelines Fail to Address COVID-19 Realities (October 23, 2020); Canadian Biotech Industry Rises to the Challenge with Release of BIONATION Policy Paper (October 1, 2020); Statement from BIOTECanada regarding PMPRB implementation delay (June 1, 2020) Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference. Product sales for Libmeldy totaled $5.1M for the first two commercial patients treated in Q1 2022 Libmeldy access and reimbursement expanding with agreements now signed in three major European . Post a press release | Manage press releases. Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 million Clinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02 Cash reserves of $5.8 million at December 31, 2020 plus funds from IPO provide funding for at least 12 months from the date of completion of the IPO COPENHAGEN . News & Press Releases Year. Press Releases; Search; Contact Us; Biotechnology News Clinical Trial Results. Dr. Ramzan Zakir selected for the International Healthcare Hero Award by IAOTP March 15, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2021 Press release 2022-04-04 Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc. . Search. SAN DIEGO, Calif., Nov. 9, 2021 Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced that Kameel Farag has joined the company as Chief Financial Officer and as a member of the company's executive . July 25, 2018. Randstad Talent Selection, la divisione di Randstad Italia focalizzata sulla Ricerca & Selezione di profili qualificati e altamente specializzati, ricerca per azienda di Forl leader in ambito nazionale ed estero settore retail un Architetto/Geometra come Impiegato Ufficio Tecnico per .